Form 4: Arcellx Director Kavita Patel Executes Option and Sells Shares Under 10b5-1 Plan

Director Kavita Patel exercised stock options and sold shares of Arcellx, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On September 10, 2024, Kavita Patel, a director of Arcellx, Inc., exercised stock options to acquire 1,500 shares of common stock at a price of $6.66 per share.
• Simultaneously, Patel sold 1,500 shares of Arcellx common stock at a price of $74.41 per share.
• The transactions were executed under a Rule 10b5-1 trading plan established on March 28, 2024.
• Following these transactions, Patel directly owns zero shares of Arcellx common stock and 63,031 stock options.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions, with no inherent positive or negative sentiment. It reflects routine financial activity.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the trading activities of company directors. The use of a 10b5-1 trading plan indicates a pre-arranged strategy to avoid accusations of trading on inside information.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders, ensuring compliance with SEC regulations.
• The use of Rule 10b5-1 trading plans is a common method for corporate insiders to manage their stock holdings while mitigating the risk of insider trading allegations, similar to practices observed at companies like Amgen and Gilead.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by slightly increasing the supply of shares in the market.
• The exercise of stock options benefits the director, Kavita Patel.

Key Dates